We are international
• health professionals TEXT SIZE   

The Nurse Leadership Board (NLB) is made up of nurses from the leading centers treating myeloma patients in the US. Their mission is to develop broad recommendations for nursing care for myeloma patients.

Key Publications
White Papers
The Advanced Practitioner's Guide to Multiple Myeloma
Managing the patient with multiple myeloma (MM) across the continuum of care is challenging given the heterogeneity of the population, the older age of most patients with MM, and the rapidly changing treatment landscape. Many practices in the community or rural settings see relatively few MM patients. This supplement to JADPRO will provide the advanced practitioner in oncology and other oncology professionals with state-of-the-science information they need to effectively manage the patient with MM. It is CME/CE/CEU accredited and provides 3 credit/contact hours for learners who access the learning assessment and evaluation form online.
Clinical Journal of Oncology Nursing: Autologous Hematopoietic Stem Cell Transplantation for Patients With Multiple Myeloma - An Overview for Nurses in Community Practice
Teresa Miceli, RN, BSN, OCN®
Kathryn Lilleby, RN
Kimberly Noonan, RN, ANP-BC
Sandra Kurtin, RN, MS, AOCN®, ANP-C
Beth Faiman, MSN, APRN-BC, AOCN®
Patricia A. Mangan, MSN, APRN-BC

IMF Nurse Leadership Board (NLB) Survivorship Care Plan for Mutliple Myeloma published in the Clinical Journal of Oncology Nursing.

Patients with myeloma are surviving longer and, therefore, may experience continuing effects of their disease and treatment. Through clinical experience, the International Myeloma Foundation Nurse Leadership Board (NLB) was aware that a specific set of needs exists in this patient population. Identification of these needs, and stressing the importance of prompt intervention, could lead to improvement in their quality of life and overall survival.

Nurse Leadership Board Guidelines for Management of Side Effects of Novel Therapies
Written by the IMF Nurse Leadership Board, made up of experienced specialty oncology nurses, these are the first comprehensive guidelines for managing side effects from lenalidomide, thalidomide, and bortezomib used in the treatment of multiple myeloma. Published in the June 2008, Supplement to Volume 12, Number 3 of the Clinical Journal of Oncology Nursing. Use the links in each article to view either a PDF or html version.

IMF Nurse Leadership Board Side Effects Fact Sheets
Part of the IMF Patient Education Tools Series, this document includes fact sheets on Preventing Blood Clots and Thromboembolic Events, Managing Myelosuppression, Managing Steroid Side Effects, Managing Peripheral Neuropathy, and Managing Gastrointestinal Side Effects With Novel Agents for Multiple Myeloma
Consensus on Care: New Insights on Novel Therapies in Multiple Myeloma
PowerPoint presentation of the consensus guidelines developed by the Nurse Leadership Board presented in an accredited satellite symposium in conjunction with the 33rd Annual Congress of the Oncology Nursing Society (ONS) in Philadelphia on May 16, 2008.